Genomma Lab Acquires the Mexican Company Medicinas y Medicamentos Nacionales
Through this new subsidiary, Genomma Lab will sell new product lines within the categories of analgesics, cold remedies, anti-fungal, anti-inflammatory, expectorants and multivitamins, among others.
Genomma Lab will apply its strategy of manufacturing these new product lines through third parties, thereby maintaining the high-quality standards that are characteristic of the Company.
Genomma Lab expects to launch the products applying Genomma's characteristic marketing and sales capabilities of its business model.
For strategic market reasons, Genomma Lab will provide additional details regarding the development of this business during second quarter 2009.
Genomma Lab Internacional, S.A.B. de C.V. is a leading over-the-counter
pharmaceuticals and personal care products company in
Genomma Lab performed its Initial Public Offering in
Web Site: www.genommalab.com Investor Relations Contact: Oscar Villalobos Tel: +52 (55) 5081 0000 Ext. 4250 E-mail: firstname.lastname@example.org In New York: i-advize Corporate Communications, Inc. Tel: (212) 406-3691/95 E-mail: email@example.com
SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.